Marc Lacroix - Publications
MOLECULAR THERAPY OF BREAST CANCER: CLASSICISM MEETS MODERNITY (book) (2009).
POOR USAGE OF HUGO STANDARD GENE NOMENCLATURE IN BREAST CANCER STUDIES (2009).
MDA-MB-435 CELLS ARE FROM MELANOMA, NOT FROM BREAST CANCER (2009).
COMPARATIVE CLINICAL AND TRANSCRIPTOMAL PROFILES OF BREAST CANCER BETWEEN FRENCH AND SOUTH MEDITERRANEAN PATIENTS SHOW MINOR BUT SIGNIFICATIVE BIOLOGICAL DIFFERENCES (2008).
TUMOR SUPPRESSOR GENES IN BREAST CANCER (book) (2008).
POOR USAGE OF HUGO STANDARD GENE NOMENCLATURE IN CANCER MARKER STUDIES (2008).
DISSEMINATED TUMOR CELLS: DETECTION, MARKERS AND PROGNOSTIC/PREDICTIVE SIGNIFICANCE (2008).
PERSISTENT USE OF "FALSE" CELL LINES (2008).
AN UPDATE ON TUMOR SUPPRESSOR GENES IN BREAST CANCER (2007).
ESTROGENS DECREASE GAMMA-RAYS INDUCED SENESCENCE AND MAINTAIN CELL CYCLE PROGRESSION IN BREAST CANCER CELLS INDEPENDENTLY OF P53 (2007).
SIGNIFICANCE, DETECTION AND MARKERS OF DISSEMINATED BREAST CANCER CELLS (2006).
HEREDITARY BREAST CANCER: AN UPDATE ON GENOTYPE AND PHENOTYPE (2006).
P53 AND BREAST CANCER, AN UPDATE (2006).
ESTROGEN RECEPTOR ALPHA: IMPACT OF LIGANDS ON INTRACELLULAR SHUTTLING AND TURNOVER RATE IN BREAST CANCER CELLS (2006).
INTERACTION BETWEEN ESTROGEN RECEPTOR ALPHA, IONIZING RADIATION AND (ANTI)-ESTROGENS IN BREAST CANCER CELLS (2005).
MOLECULAR CHARACTERIZATION OF BREAST CANCER CELL LINES BY A LOW-DENSITY MICROARRAY (2005).
THE PORTRAIT OF HEREDITARY BREAST CANCER (2005).
AN UPDATED VIEW ON CELL LINES AS IN VITRO MODELS FOR BREAST TUMORS (2004).
GENE REGULATION BY PHORBOL 12-MYRISTATE 13-ACETATE (PMA) IN MCF-7 AND MDA-MB-231, TWO BREAST CANCER CELL LINES EXHIBITING HIGHLY DIFFERENT PHENOTYPES (2004).
GENOMIC AND MOLECULAR CLASSIFICATION OF BREAST CANCER (2004).
STABLE PORTRAIT OF BREAST TUMORS DURING PROGRESSION. DATA FROM BIOLOGY, PATHOLOGY, AND GENETICS (2004).
ABOUT
GATA3
,
HNF3A
AND
XBP1
, THREE GENES CO-EXPRESSED WITH THE OESTROGEN RECEPTOR-ALPHA GENE (
ESR1
) IN BREAST CANCER (2004).
RELEVANCE OF BREAST CANCER CELL LINES AS MODELS FOR BREAST TUMOURS: AN UPDATE (2004).
MECHANISMS REGULATING OESTROGEN RECEPTOR ALPHA EXPRESSION IN BREAST CANCER (2002).
ESTROGENIC EFFECT OF A SERIES OF BISPHENOL ANALOGUES ON GENE AND PROTEIN EXPRESSION IN MCF-7 BREAST CANCER CELLS (2002).
A LOW-DENSITY DNA MICROARRAY FOR ANALYSIS OF MARKERS IN BREAST CANCER (2002).
ESTROGEN RECEPTOR ANALYSIS IN PRIMARY BREAST TUMORS BY LIGAND-BINDING ASSAY, IMMUNOCYTOCHEMICAL ASSAY, AND NORTHERN BLOT: A COMPARISON (2001).
INTERLEUKINS-6 AND -11 EXPRESSION IN PRIMARY BREAST CANCER AND SUBSEQUENT DEVELOPMENT OF BONE METASTASES (2001).
ESTROGEN RECEPTORS OF PRIMARY BREAST CANCERS: EVIDENCE FOR INTRACELLULAR PROTEOLYSIS (2000).
PROTEIN PRODUCTION BY OSTEOBLASTIC CELLS: MODULATION BY BREAST CANCER CELL-DERIVED FACTORS (2000).
THE ASPIRIN METABOLITE SALICYLATE INHIBITS BREAST CANCER CELLS GROWTH AND THEIR SYNTHESIS OF THE OSTEOLYTIC CYTOKINES INTERLEUKINS-6 AND -11 (1999).
ESTABLISHMENT AND CHARACTERIZATION OF THREE NEW BREAST-CANCER CELL LINES (1998).
BREAST CANCER CELL RESPONSE TO CALCITONIN: MODULATION BY GROWTH-REGULATING AGENTS (1998).
PRODUCTION AND REGULATION OF INTERLEUKIN-11 BY BREAST CANCER CELLS (1998).
REGULATION OF C-FOS AND C-JUN EXPRESSION BY CALCITONIN IN HUMAN BREAST CANCER CELLS (1997).
SECRETORY PRODUCTS OF BREAST CANCER CELLS SPECIFICALLY AFFECT HUMAN OSTEOBLASTIC CELLS: PARTIAL CHARACTERIZATION OF ACTIVE FACTORS (1997).
ESTROGEN RECEPTOR-NEGATIVE/PROGESTERONE RECEPTOR-POSITIVE EVSA-T MAMMARY TUMOR CELLS: A MODEL FOR ASSESSING THE BIOLOGICAL PROPERTIES OF THIS PECULIAR PHENOTYPE OF BREAST CANCERS (1997).
EFFECTS OF SECRETORY PRODUCTS OF BREAST CANCER CELLS ON OSTEOBLAST-LIKE CELLS (1996).
ANTIESTROGENIC ACTIVITY OF TWO 11ß-ESTRADIOL DERIVATIVES ON MCF-7 BREAST CANCER CELLS (1995).
KERATINOCYTES MODULATE THE BIOSYNTHETIC PHENOTYPE OF DERMAL FIBROBLASTS AT A PRETRANSLATIONAL LEVEL IN A HUMAN SKIN EQUIVALENT (1995).
REGULATION OF LYMPHOCYTE CALCITONIN RECEPTORS BY INTERLEUKIN-1 AND INTERLEUKIN-6 (1994).
Webmaster / Webmestre:
Marc Lacroix
This page hosted by/Page hébergée par
Get your own
Free Home Page
/Obtenez votre
page personnelle gratuite
Made in BELGIUM / WALLONIA / EUREGIO MAAS-RHINE - Fait en BELGIQUE / WALLONIE / EUREGIO MEUSE-RHIN - (Molecular breast cancer - Cancer du sein, aspects moléculaires) Marc Lacroix & SciMedWeb® & InTextoResearch® 1997-2009
